Cited by 260Wnt/β-catenin signaling in development and cancerHedgehog Signaling Pathway StudiesColorectal Cancer Treatments and Studies

WNT as a Driver and Dependency in Cancer

Open access
Parsons, Marie J., Tammela, Tuomas, Dow, Lukas E.·2021·Cancer Discovery

Abstract

The WNT signaling pathway is a critical regulator of development and adult tissue homeostasis and becomes dysregulated in many cancer types. Although hyperactivation of WNT signaling is common, the type and frequency of genetic WNT pathway alterations can vary dramatically between different cancers, highlighting possible cancer-specific mechanisms for WNT-driven disease. In this review, we discuss how WNT pathway disruption contributes to tumorigenesis in different organs and how WNT affects the tumor cell and immune microenvironment. Finally, we describe recent and ongoing efforts to target oncogenic WNT signaling as a therapeutic strategy. Significance: WNT signaling is a fundamental regulator of tissue homeostasis and oncogenic driver in many cancer types. In this review, we highlight recent advances in our understanding of WNT signaling in cancer, particularly the complexities of WNT activation in distinct cancer types, its role in immune evasion, and the challenge of targeting the WNT pathway as a therapeutic strategy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-21-0190

Cites

196 of 196 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Wnt/β-catenin pathway plays a critical role in maintaining the cancer stem cell population in malignant tissues, making Wnt a potential target in CRC.

    “The Wnt/β-catenin pathway also plays a critical role in maintaining the cancer stem cell (CSC) population in malignant tissues making Wnt a potential target in CRC [109]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [125]Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M. Diminished WNT -> beta-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes Dev 2014; 28(6): 561– 75 doi 10.1101/gad.233627.113. 24589553 PMC3967046 · DOI
  2. [157]Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell 2016; 165(1): 45– 60 doi 10.1016/j.cell.2016.02.025. 27015306 PMC4808520 · DOI · Paper page
  3. [168]Waaler J, Leenders RGG, Sowa ST, Alam Brinch S, Lycke M, Nieczypor P, Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor. J Med Chem 2020 doi 10.1021/acs.jmedchem.0c00208. PMC8008393 32511917 · DOI

Cited by

Sorted by citations

Authors
Parsons, M. J., Tammela, T., & Dow, L. E.
Affiliations
  • Weill Cornell Medicine (US)
  • Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Dow, Lukas E.
Venue
Cancer Discovery
Published
2021-09-13
Volume
11
Issue
10
Pages
2413-2429
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3199697997
Cited by
257
References
195
Citations by year
2026: 36 · 2025: 50 · 2024: 70 · 2023: 56 · 2022: 41 · 2021: 4
FWCI
4.56
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Cancer Society (131461-RSG-17-202-01-TBG)
  • NCI (1R01CA222517-01A1)
  • Starr Cancer Consortium (SCC I14-0023)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
Wnt signaling, carcinogenesis, tumor immune microenvironment, immune evasion, Wnt pathway inhibitors, cancer therapy, tissue homeostasis
MeSH terms
Humans, Neoplasms, Tumor Microenvironment, Wnt Signaling Pathway, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review